导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.06% | 878/1050 |
| 近一周 | -2.80% | 734/1104 |
| 近一月 | -6.08% | 734/1102 |
| 近一季 | -19.71% | 971/1092 |
| 近半年 | -16.91% | 932/1070 |
| 近一年 | -2.45% | 628/1018 |
| 近两年 | 40.86% | 574/926 |
| 近三年 | 32.06% | 376/834 |
| 成立以来 | 116.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.18% 726/1070 |
20.00% 390/1101 |
- - |
- - |
| 2025 | 41.30% 305/1065 |
-2.18% 919/1014 |
4.44% 332/1038 |
27.69% 398/1050 |
8.32% 67/1065 |
| 2024 | 11.06% 264/1011 |
9.18% 36/960 |
3.58% 138/983 |
2.78% 923/991 |
-4.44% 631/1011 |
| 2023 | -23.35% 748/952 |
-3.12% 750/880 |
0.08% 186/895 |
-16.87% 815/915 |
-4.90% 487/952 |
| 2022 | -20.44% 343/867 |
-15.79% 298/773 |
6.84% 418/806 |
-7.01% 108/845 |
-4.90% 648/867 |
| 2021 | 24.01% 123/740 |
-5.07% 342/580 |
16.36% 213/659 |
9.11% 77/704 |
2.90% 309/740 |
| 2020 | - - |
- - |
12.94% 377/466 |
21.85% 40/517 |
33.45% 30/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 建信高股息主题股票 VS. 东吴新产业精选股票A(580008) |